Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Sonia Jaramillo Segura, Maxi Wass, Judith Schaffrath, Kathrin Rieger, Axel Nogai, Mathias Haenel, Regina Herbst, Friedrich Stoelzel, Christoph Röllig, Edgar Jost, Richard F. Schlenk, Richard Noppeney, Christian H. Brandts, Utz Krug, Katharina S. Goetze, Sebastian Buske, Axel Florschütz, Jörg Schubert, Bernhard Opitz, Martin Mohren, Eva Eßeling, Stephan von Witzendorff, Marion Subklewe, Martin Kaufmann, Norbert Frickhofen, Christian W Scholz, Kerstin Schäfer-Eckart, Volker Kunzmann, Martin Schmidt-Hieber, Herbert G. Sayer, Andreas Rank, Philipp Hemmati, Frank Schueler, Simone Kowoll, Marina Scheller, Jörg Steighardt, Bayram Edemir, Lutz Peter Mueller, Irit Gliko-Kabir, Beatrice Ludwig-Kraus, Sabine Edemir, Ella Sorani, Mascha Binder, Abi Vainstein, Shaul Kadosh, Cora Gromann, Andreas Wienke, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhaeuser, Christian Junghanss, Carsten Mueller-Tidow

Blood (2022) 140 (Supplement 1): 3338–3340.

https://doi.org/10.1182/blood-2022-166748

Published: 2022

Journal Articles

Therapy-Related AML: Clinical/Biological Features and Long-Term Outcome in a Cohort of 1133 Adult AML Patients

Sophia Gross, Jana Ihlow, Leonie Busack, Kacper Adamiak, Jens F. Schrezenmeier, Julia Jesse, Michaela Schwarz, Anne Floercken, Kathrin Rieger, Jan Krönke, Philipp le Coutre, Vivien Boldt, Ann-Christin von Bruenneck, David Horst, Thomas Burmeister, Igor Wolfgang Blau, Ulrich Keller, Lars Bullinger, Joerg Westermann

Blood (2022) 140 (Supplement 1): 1291–1292.

https://doi.org/10.1182/blood-2022-164798

Published: 2022

Journal Articles

Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) - Real-World Data from Two German Academic Centers

Laura K. Schmalbrock, Krischan Braitsch, Paul Jung, Irmgard Bumeder, Philipp Kiewe, Jörg Westermann, Lars Bullinger, Ulrich Keller, Florian Bassermann, Jan Krönke, Kathrin Rieger, Katharina S. Goetze

Blood (2021) 138 (Supplement 1): 1257.

https://doi.org/10.1182/blood-2021-150943

Published: 2021

Journal Articles

Quantitative Detection of DNMT3A R882H Mutation in Course of Treatment of Acute Myeloid Leukemia Patients

Olga Blau, MD PhD, Rimma Berenstein, Claudia Baldus, MD PhD, Nikola Suckert, Kathrin Rieger, MD, Axel Nogai, MD, Antonio Pezzutto, MD PhD, Bernd Doerken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2015) 126 (23): 4970.

https://doi.org/10.1182/blood.V126.23.4970.4970

Published: 2015

Journal Articles

Cyclin D1 C.870G>a Polymorphism in Patients with Multiple Myeloma after Allogeneic Stem Cells Transplantation

Olga Blau, MD PhD, Ekaterina Slonova, Rimma Berenstein, Axel Nogai, MD, Kathrin Rieger, MD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Igor Wolfgang Blau, MD PhD

Blood (2014) 124 (21): 2576.

https://doi.org/10.1182/blood.V124.21.2576.2576

Published: 2014

Journal Articles

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Christoph Ochs, Philipp Hemmati, MD, Giang Lam Vuong, MD, Kathrin Rieger, Olga Blau, Jörg Westermann, MD, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2013) 122 (21): 4605.

https://doi.org/10.1182/blood.V122.21.4605.4605

Published: 2013

Journal Articles

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Kristina Allers, Gero Hütter, Jörg Hofmann, Christoph Loddenkemper, Kathrin Rieger, Eckhard Thiel, Thomas Schneider

Blood (2011) 117 (10): 2791–2799.

https://doi.org/10.1182/blood-2010-09-309591

Published: 2011

Journal Articles

Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) In Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Interim-Analysis From the AZARELA-Trial (NCT-00795548).

Thomas Schroeder, Akos Gabor Czibere, Nicolaus Kröger, Uwe Platzbecker, Gesine Bug, Kathrin Rieger, Thomas Luft, Ingmar Bruns, Fabian Zohren, Christine Wolschke, MD, Roland Fenk, Rainer Haas, Guido Kobbe, MD

Blood (2010) 116 (21): 1294.

https://doi.org/10.1182/blood.V116.21.1294.1294

Published: 2010

Journal Articles

Mucosal FOXP3 + regulatory T cells are numerically deficient in acute and chronic GvHD

Kathrin Rieger, Christoph Loddenkemper, Jochem Maul, Thomas Fietz, Daniel Wolff, Harald Terpe, Beate Steiner, Erika Berg, Stephan Miehlke, Martin Bornhäuser, Thomas Schneider, Martin Zeitz, Harald Stein, Eckhard Thiel, Rainer Duchmann, Lutz Uharek

Blood (2006) 107 (4): 1717–1723.

https://doi.org/10.1182/blood-2005-06-2529

Published: 2006

Journal Articles

Mucosal Foxp3 + Regulatory T Cells Show Significant Numerical Differences in Patients with Intestinal Graft-Versus-Host Disease Compared to Infectious Diseases of the Gut.

Kathrin Rieger, Christoph Loddenkemper, Jochen Maul, Thomas Fietz, Daniel Wolff, Harald Terpe, Beate Steiner, Erika Berg, Stefan Miehlke, Martin Bornhaeuser, Thomas Schneider, Martin Zeitz, Harald Stein, Eckhard Thiel, Lutz Uharek

Blood (2005) 106 (11): 596.

https://doi.org/10.1182/blood.V106.11.596.596

Published: 2005

Journal Articles

Real-Time Quantitative Y Chromosome Specific PCR vs. XY-FISH vs. Fluorescent STR-PCR for Chimerism Analysis after Allogeneic Sex-Mismatched PBSCT.

Ulrike Baak, MD, Olga Marinets, MD, Kathrin Rieger, MD, Igor Wolfgang Blau, MD, Lutz Uharek, MD, Thomas Burmeister, MD, PhD, Eckhard Thiel, MD.

Blood (2004) 104 (11): 5047.

https://doi.org/10.1182/blood.V104.11.5047.5047

Published: 2004

NARROW

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Therapy-Related AML: Clinical/Biological Features and Long-Term Outcome in a Cohort of 1133 Adult AML Patients

Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) - Real-World Data from Two German Academic Centers

Quantitative Detection of DNMT3A R882H Mutation in Course of Treatment of Acute Myeloid Leukemia Patients

Cyclin D1 C.870G>a Polymorphism in Patients with Multiple Myeloma after Allogeneic Stem Cells Transplantation

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) In Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Interim-Analysis From the AZARELA-Trial (NCT-00795548).

Mucosal FOXP3 + regulatory T cells are numerically deficient in acute and chronic GvHD

Mucosal Foxp3 + Regulatory T Cells Show Significant Numerical Differences in Patients with Intestinal Graft-Versus-Host Disease Compared to Infectious Diseases of the Gut.

Real-Time Quantitative Y Chromosome Specific PCR vs. XY-FISH vs. Fluorescent STR-PCR for Chimerism Analysis after Allogeneic Sex-Mismatched PBSCT.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only